(Press-News.org) (Boston) - Researchers from Boston University School's of Medicine (BUSM), Management (SMG) and Law (LAW), along with collaborators from the National Institutes of Health, believe that public-sector research has had a more immediate effect on improving public health than was previously realized. The findings, which appear as a Special Article in the February 10th issue of The New England Journal of Medicine, have economic and policy implications.
Historically, public sector research institutions (PSRI) have not participated in any major way in the downstream, applied phase of drug discovery, in which the actual products are discovered and patented. However, in the mid-1970s, the newly emerging tools of biotechnology allowed PSRIs to create and patent biologic drug candidates and discover and patent small molecule drugs. At that time, all products created in academic institutions were owned by the government, which granted only nonexclusive licenses.
In 1980, Congress passed two pieces of legislation that transformed the ownership, management and transfer of intellectual property that is created by PSRIs. First, the Bayh–Dole Act allowed universities, nonprofit research institutes and teaching hospitals to own the intellectual property resulting from federally funded research and to license it according to terms of their choosing. Second, the Stevenson–Wydler Technology Innovation Act as amended by the Federal Technology Transfer Act of 1986, provided a corresponding authority to federal laboratories. Under this new approach, inventions that arose from PSRIs, in addition to being freely published in the scientific literature, could also be converted into intellectual property and transferred through license agreements to the private sector for commercialization and public use.
In order to quantitate the contribution of public-sector research to the applied-research phase of drug discovery, the researchers identified new drugs and vaccines approved by the Food and Drug Administration (FDA) and classified them according to their therapeutic category and potential therapeutic effect. The researchers found that during the past 30 years, 153 new FDA-approved drugs, vaccines, or new indications for existing drugs were discovered through research carried out in PSRIs. These drugs included 93 small-molecule drugs, 36 biologic agents, 15 vaccines, eight in-vivo diagnostic materials, and one over-the-counter drug. Current and former Boston University researchers were responsible for four of those 153 new drugs, one of which was developed based on research conducted at the University and Boston Medical Center.
"We believe that our study supports the concept that the emergence of biotechnology in the mid-1970s, combined with policy changes implemented in the early 1980s regarding the ownership and management of the intellectual property of PSRIs, allowed these institutions to play an important role in the downstream, applied phase of drug discovery," said lead author Ashley J. Stevens, D.Phil (Oxon), CLP, a lecturer at BUSM as well as Special Assistant to the Vice President for Research, Technology Development and a Senior Research Associate, ITEC, SMG. He is also currently the President of the Association of University Technology Managers.
According to the researchers, the data also suggest that PSRIs tend to discover drugs that have a disproportionately important clinical effect. "Slightly over half of these drugs were for the treatment or prevention of cancer or infectious diseases. Furthermore, drugs discovered by PSRIs received Priority Review by the FDA at twice the rate as for all FDA drug approvals, indicating that PSRI discovered drugs were expected to have a disproportionately high therapeutic impact," added Stevens.
"We hope our research will help inform the amplified conversation taking place around innovation policy in the US and abroad," said co-author Jonathan Jensen, MBA, Director, Business Development, Technology Development at Boston University. "The factors involved in bringing a single one of these drugs to market are complex. With a more comprehensive understanding of the contribution of the public sector to the development of FDA approved drugs, as our work attempts to establish, one can better appreciate and further study the factors involved in the transfer of knowledge from the public to the private sector," he added.
###
Patrick Kilgore, a second-year law school student at BU, Mark L. Rohrbaugh, PhD, JD, and Sabarni Chatterjee, PhD, MBA, from the Office of Technology Transfer at the National Institutes of Health, and Katrine Wyller, MBE, from the Norwegian
Radium Hospital Research Foundation, Oslo, were also authors on this study.
Researchers find public sector research responsible for many new drug discoveries
2011-02-10
ELSE PRESS RELEASES FROM THIS DATE:
Scientists discover gene regulation mechanism unique to primates
2011-02-10
Scientists have discovered a new way genes are regulated that is unique to primates, including humans and monkeys. Though the human genome – all the genes that an individual possesses – was sequenced 10 years ago, greater understanding of how genes function and are regulated is needed to make advances in medicine, including changing the way we diagnose, treat and prevent a wide range of diseases.
"It's extremely valuable that we've sequenced a large bulk of the human genome, but sequence without function doesn't get us very far, which is why our finding is so important," ...
Scripps Research study presents surprising view of brain formation
2011-02-10
LA JOLLA, CA – Embargoed by the journal Neuron until February 9, 2011, noon, Eastern time – A study from The Scripps Research Institute has unveiled a surprising mechanism that controls brain formation. The findings have implications for understanding a host of diseases, including some forms of mental retardation, epilepsy, schizophrenia, and autism.
The research, led by Scripps Research Professor Ulrich Mueller, was published in the journal Neuron on February 10, 2011.
In the new study, Mueller and colleagues focused on a protein called reelin. They found reelin is ...
Fetal surgery, pioneered at UCSF, is more effective than operating after birth
2011-02-10
Thirty years ago, the first human fetal surgery was performed at the University of California, San Francisco. Now, a randomized controlled trial has proven definitively that fetal surgery can help certain patients before birth.
Babies who undergo an operation to repair the birth defect spina bifida while still in the womb develop better and experience fewer neurologic complications than babies who have corrective surgery after birth, according to findings from a major multicenter trial led by UCSF researchers. The study is the first to systematically evaluate the best ...
New hybrid drug, derived from common spice, may protect, rebuild brain cells after stroke
2011-02-10
LOS ANGELES (EMBARGOED UNTIL FEB. 9, 2011 AT 9:15 PM EST) – Whether or not you're fond of Indian, Southeast Asian and Middle Eastern food, stroke researchers at Cedars-Sinai Medical Center think you may become a fan of one of their key spices.
The scientists created a new molecule from curcumin, a chemical component of the golden-colored spice turmeric, and found in laboratory experiments that it affects mechanisms that protect and help regenerate brain cells after stroke. Research scientist Paul A. Lapchak, Ph.D., director of Translational Research in the Department ...
Simple marine worms distantly related to humans
2011-02-10
Two groups of lowly marine worms are related to complex species including vertebrates (such as humans) and starfish, according to new research. Previously thought to be an evolutionary link between simple animals such as jellyfish and the rest of animal life - the worms' surprising promotion implies that they have not always been as simple as they now appear.
Although the marine worms Xenoturbella and Acoelomorpha are very simple animals – they lack a developed nervous system or gut – they have been a source of much debate among zoologists. Acoelomorphs were reclassified ...
Memory problems may be sign of stroke risk
2011-02-10
ST. PAUL, Minn. – People who have memory problems or other declines in their mental abilities may be at higher risk for stroke, according to a study released today that will be presented at the American Academy of Neurology's 63rd Annual Meeting in Honolulu April 9 to April 16, 2011.
"Finding ways to prevent stroke and identify people at risk for stroke are important public health problems," said study author Abraham J. Letter of the University of Alabama at Birmingham. "This study shows we might get a better idea of who is at high risk of stroke by including a couple ...
NHGRI charts course for the next phase of genomics research
2011-02-10
A new strategic plan from an arm of the National Institutes of Health envisions scientists being able to identify genetic bases of most single-gene disorders and gaining new insights into multi-gene disorders in the next decade. This should lead to more accurate diagnoses, new drug targets and the development of practical treatments for many who today lack therapeutic options, according to the plan from the National Human Genome Research Institute (NHGRI).
Molecular pathways that are implicated in single-gene disorders may hold important clues for the diagnosis and treatment ...
UK companies respond to recession by 'training smarter,' study finds
2011-02-10
Fears that most UK companies would slash investment in skills training as a result of the recession have proved to be largely unfounded, researchers at Cardiff University and the University of London have concluded. Although some employers have cut spending to the bone, total expenditure on training has reduced only slightly.
Many employers are also "training smarter", according to a new study from researchers at Cardiff University and the Centre for Learning and Life Chances in Knowledge Economies and Societies (LLAKES), at the Institute of Education, University of ...
Fetal surgery takes a huge step forward in treating children with spina bifida
2011-02-10
Performing delicate surgery in the womb, months before birth, can substantially improve outcomes for children with a common, disabling birth defect of the spine. Experts at The Children's Hospital of Philadelphia (CHOP) co-led a new landmark study showing that fetal surgery for spina bifida greatly reduces the need to divert fluid from the brain, improves mobility and improves the chances that a child will be able to walk independently.
Spina bifida is the most common birth defect of the central nervous system, affecting about 1,500 babies born each year in the United ...
Hearing with your nose: How nasal stem cells could tackle childhood hearing problems
2011-02-10
Stem Cell scientists in Australia have found that patients suffering from hearing problems which began during infancy and childhood could benefit from a transplant of stem cells from their nose. The research, published today in STEM CELLS, reveals that mucosa-derived stem cells can help preserve hearing function during the early-onset of sensorineural hearing loss.
Sensorineural hearing loss is caused by the loss of sensory cells or neurons in the cochlea, the sensory organ of the inner ear responsible for hearing. The condition can have genetic causes, often arising ...